ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6,1,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
6,2,Splenic vein thrombosis,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
7,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
8,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
8,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
9,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
10,3,Electrocardiogram delta waves abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
10,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10,6,Myocardial necrosis marker increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
10,7,Ventricular dyskinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
11,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
12,2,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
13,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
14,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
15,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
15,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
16,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
18,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
18,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
18,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,9,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
18,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
19,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
22,1,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
23,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
23,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
25,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,3,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
25,4,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
25,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,6,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
26,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
27,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
28,1,Creutzfeldt-Jakob disease,Prion-associated disorders,Viral infectious disorders,Infec,N
29,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
29,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
30,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
30,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
31,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
33,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
34,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
34,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
34,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
35,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
35,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,3,Drug exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
35,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
35,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
35,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
35,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
36,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
38,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
39,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
39,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
39,3,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
39,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
39,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
39,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
39,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,10,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
39,11,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
39,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,14,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
39,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
40,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
40,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
40,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
40,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
40,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
40,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,10,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
40,11,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
40,12,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
41,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
41,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
42,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
42,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
44,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
44,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
45,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
45,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,4,Von Willebrand's factor antibody positive,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
46,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
46,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
46,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
46,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
46,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
46,6,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
46,7,Transfusion-related circulatory overload,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
47,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
47,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
47,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
47,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
48,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
48,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
49,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
50,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
51,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
52,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
53,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
54,1,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
55,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
55,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
57,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
58,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
59,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
59,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
59,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
59,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
59,6,Von Willebrand's disease,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
59,7,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
60,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
61,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,5,Von Willebrand's factor inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
62,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
63,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
63,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
63,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,1,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
67,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
70,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
72,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
73,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
74,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
75,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
75,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
76,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
77,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
77,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
77,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
79,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
79,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
79,4,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
80,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
80,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
82,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
83,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
84,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
85,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,1,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
87,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
89,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
90,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
90,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
90,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
90,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
91,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
93,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
93,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
94,1,Headache,Headaches NEC,Headaches,Nerv,N
94,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
94,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
94,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
